Clinical Trials Browser

Myelodysplastic Syndromes × ceralasertib × 90 days × Clear all

NCT03770429 2026-05-11

AZD6738 for Patients With Progressive MDS or CMML

Phase 1 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes